INDIAN FACE
INDIAN EQUITY BENCHMARK
Equity benchmark indices
extended its rally in the morning trade Tuesday and are trading
near day’s high. The Bank Nifty and Sensex hit a record high,
with the Nifty50 just 40 points away from its record high level.
The Bank Nifty hit a new record high of 32,197.60 level, shares
of Yes Bank climbed 2% and are among the top contributors to
the index gain. Shares of Bank of Baroda, Punjab National Bank,
RBL Bank, SBI and IndusInd Bank rose 1% each, followed by Axis
Bank, Kotak Mahindra Bank, HDFC Bank, ICICI Bank and IDFC
First Bank were the other top gainers on the Bank Nifty index.
However, Federal Bank is the only loser on the Bank Nifty index.
U.S. Market – North and South American markets finished mixed as of the most recent closing prices. The S&P 500 gained 0.71% and the IPC rose 0.23%. The Bovespa lost 0.59%.
European markets- European markets are lower today with shares in Germany off the most. The DAX is down 0.35% while France's CAC 40 is off 0.26% and London's FTSE 100 is lower by 0.01%.
NIFTY SPOT
MARKET TALKS
HDFC, IOC, Axis Finance and GIC Housing Finance list their Commercial Paper on BSE
Housing Development Finance Corporation Limited (HDFC), Indian Oil Corporation Limited (IOC), Axis Finance Limited and GIC Housing Finance Limited made an application to list Commercial Paper at BSE for an Issue Size of Rs2,000cr, Rs1,600cr, Rs275cr and Rs200cr respectively. Post-process, the effective date of listing for the same at BSE is December 17, 2019. Till date, 12 Issuers have done 23 issuances of Commercial Paper and have successfully listed Rs14, 220cr on BSE. The weighted average yield of these issuances is 5.20% with an average tenor of 98 days.
Linde India gets Rs1,380cr from Air Water India as per biz transfer agreement
Shares of Linde India rose over 2% on the BSE after the
company has received the full purchase consideration of Rs1,
380cr from Air Water India Pvt. Ltd. as per the terms of the
aforesaid Business Transfer Agreement. “This is to inform you
that in compliance with the Competition Commission of
India's (CCI) Order on September 6, 2018, the Company has
yesterday, effective close of business hours, consummated
and closed the Business Transfer Agreement for divestment
of the 'South Region Divestment Business,' which was signed
on November 22, 2019, with Air Water India Pvt. Ltd. (the
purchaser) and Air Water Inc.
Shriram Transport Finance drops after
S&P changes outlook to negative
Indoco Remedies announced that its sterile manufacturing
facility (Plant II) at Verna, Goa, has received EU GMP
certification from the UK Health Regulator. This is an
outcome from the last successful inspection conducted by UK
MHRA from 16th to 20th September 2019. Commenting on
this positive development, Ms. Aditi Kare Panandikar,
Managing Director – Indoco Remedies Ltd. said, “The receipt
of EU GMP certification from MHRA for our sterile
manufacturing unit is encouraging and reflectsimmense
learning and adaptation of a compliant culture by our
technical team."
Lupin announces completion of Kyowa
divestiture to Unison; stock up 1%
Pharma major Lupin announced that its subsidiary, Nanomi
B.V. has completed the divestiture of the entire stake by
99.82% in Kyowa Pharmaceutical Industry Co. Ltd. (Kyowa)
to Unison Capital Partners IV, LPS and Unison Capital
Partners IV (F). L.P. (collectively referred to as ‘Unison’),
pursuant to the satisfactory completion of all customary
closing conditions. The divestiture, which valued Kyowa at
an Enterprise Value of JPY 57,361 million, was announced
on November 11, 2019, and approved by Lupin’s
shareholders.
NAME OF THE STOCK : BAJAJ FINANCE
DATE : 18/12/2019
SEGMENT : CASH
CHART TYPE : Candlestick
EXCHANGE : NSE
TECHNICAL INDICATORS USED : VOLUME.MACD, RSI.
INVESTMENT ADVICE:
CALL CS CALL: BUY BAJAJFIANCE CASH NR CMP 4135 TGT 4235 SL 4060
RATIONALE FOR ARRIVING INVESTMENT ADVICE :
THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH
HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE.
OTHER REASON IF ANY : SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL
DISCLAIMER
The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decisions. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk.
CLICK HERE FOR GETTING DETAILS & JOIN OUR BEST ADVISORY -
CAPITALSTARS CALL US : 9977499927
Derivatives Tips , Intraday Stock Tips , FreeTrading Tips, Sebi Registered advisory
0 Comments